Today's 9 generics reviews: 6 for the first 3 injections

On November 19, NMPA issued a batch of nine generics that passed a consistent review, six of which were the first to be evaluated, including three injection varieties, cephalosporine for injections by Yangzijiang Pharmaceuticals and Ida Laven injections from Syngenta Pharmaceuticals.
injection of cephalosporine sodium, Yangzijiang's first evaluation of Insight database shows that the current injection of cephalosporine sodium, including Yangzijiang, six enterprises have submitted a consistent evaluation of supplementary applications, involving 15 regulations.
Yangzijiang Pharmaceuticals was the first to submit a supplementary application, and this is also the first review.
from: Insight database () Ida Lafeng injection, the first sound pharmaceutical industry to review The Insight database shows that Idalafeng this variety includes Ida Lafon sodium chloride injection and Idalafeng injection two specifications, the former is Zhengda Fenghai was approved and evaluated in January 2020 with a new registration category, which has been reviewed by eight companies, including Synod, and four companies have submitted new registration classification listing applications.
First Voice Pharmaceuticals was also the first company to apply, submitting a conformity evaluation supplement in October 2018.
from: Insight Database ()